Biologistex CCM, LLC, a joint venture of BioLife Solutions, Inc. and SAVSU Technologies, have entered a partnership with MNX Global Logistics, a global provider of specialized, expedited transportation and logistics services, to offer enhanced cold chain logistics services to the biopharma, biobanking, and regenerative medicine markets via the biologistex SaaS app.

Biolife and SAVSU are both developers and manufacturers of temperature controlled media for storage of healthcare products. MNX offers specialized, expedited transportation and logistics services to ensure mission critical APIs, cord blood, manufactured cell products, and other biologics are securely transported and delivered on time to the intended destination.

MNX and biologistex have agreed to integrate their respective IT systems to enable users of the biologistex cloud based cold chain logistics app to directly order and purchase MNX support and logistic services, including next flight out, same day delivery and door to door professional courier pickup and delivery of time and temperature sensitive biologic shipments.

“We continually add products and services to our offering that enhance the value that we bring to our customers,” said Paul J. Martins, Chief Executive Officer at MNX. “The evo Smart Shipper and biologistex cloud SaaS complement our drive to leverage cutting-edge technologies that help simplify cold-chain shipments for customers in the cell therapy and regenerative medicine markets.”

“A key goal of our biologistex joint venture with SAVSU Technologies is to provide solutions to help our life sciences customers optimize cold chain logistics,” said Mike Rice, BioLife’s CEO. “MNX logistics services, specifically door to door same day delivery, offer our customers the peace of mind of secure delivery of life saving cell-based therapies, with enhanced shipment monitoring and alerts at a fraction of the cost of traditional specialty couriers, while eliminating the risk of delayed shipment delivery from multi-leg air cargo flights and the potential for packages to get stuck in a connecting hub.”

BioLife Solutions has built a franchise in the regenerative medicine market by gaining a critical mass of cell therapy customers including most of the private and public immuno-oncology companies developing various T cell immunotherapies to treat blood cancers and solid tumors. To date, BioLife’s CryoStor and HypoThermosol biopreservation media products have been embedded into more than 200 pre-clinical validations and clinical trials of novel cell based products and therapies targeting the leading causes of death and disability.

SAVSU Technologies is the designer and supplier of the award winning evo Smart Shipper to the biologistex joint venture.